| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8533779 | Journal of Pharmacological and Toxicological Methods | 2018 | 4 Pages |
Abstract
This is the first set-up of a PEA-based assay for quantification of bevacizumab in human plasma. Its good performance and high sensitivity support further evaluation for potential uses particularly when the expected concentrations are low.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Ivana MikaÄiÄ, Robert BelužiÄ, Oliver Vugrek, Äuro PlavljaniÄ,